Tilray (TLRY)
NASDAQ:TLRY
Want to see TLRY full AI Analyst Report?
TLRY Stock Chart & Stats
$6.86
-$0.07(-5.17%)
At close: 4:00 PM EST
$6.86
-$0.07(-5.17%)
Day’s Range― - ―
52-Week Range$3.50 - $23.20
Previous CloseN/A
Volume22.72M
Average Volume (3M)6.37M
Market Cap
$643.47M
Enterprise Value$771.48M
Total Cash (Recent Filing)$219.93M
Total Debt (Recent Filing)$317.08M
Price to Earnings (P/E)―
Beta1.04
Next Earnings
Jul 29, 2026EPS Estimate
>-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-18.61
Shares Outstanding119,604,225
10 Day Avg. Volume3,192,480
30 Day Avg. Volume6,373,731
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.18
Price to Sales (P/S)0.34
P/FCF Ratio-2.17
Enterprise Value/Market Cap1.20
Enterprise Value/Revenue0.65
Enterprise Value/Gross Profit2.36
Enterprise Value/Ebitda-0.42
Forecast
1Y Price Target
$7.97Price Target Upside16.21% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
EPS Forecast (FY)-0.33
Revenue Forecast (FY)$1.10B
Bulls Say, Bears Say
Bulls Say
Beverage Platform ExpansionTilray’s BrewDog acquisition and the Carlsberg U.S. licensing agreement materially expand its beverage scale and diversify revenue beyond cannabis. A larger, integrated craft-beverage platform supports distribution leverage, brand cross-selling and steadier cash generation potential over the next 2–6 months.
Improving Core Profitability And GuidanceConsistent adjusted-EBITDA improvement and a reaffirmed multiyear target indicate operational leverage and tighter cost control. This suggests management can grow underlying cash profitability even as revenue mix shifts, improving sustainability of margins over the medium term.
Structural Cost Savings (Project 420)Realized, recurring cost reductions from Project 420 lower the company’s structural cost base and improve beverage gross-margin runway. Annualized savings materially reduce the required revenue growth rate to reach break-even and strengthen margin resilience amid input-cost volatility.
Bears Say
Large GAAP Losses And Negative Free Cash FlowSustained, sizeable GAAP losses and negative free cash flow erode equity and limit internal funding capacity. Over several quarters this increases reliance on external capital, constrains reinvestment, and raises solvency risk if operating improvement falters, making long-term funding more expensive.
Reliance On External FinancingThe ATM facility signals ongoing dependence on capital markets to fund growth and integration costs. Persistent negative FCF plus periodic equity issuance can dilute shareholders, constrain strategic optionality, and reflects that operations are not yet self-sustaining without external funding.
U.S. Regulatory Uncertainty For Hemp/cannabisRegulatory shifts in the U.S., including potential limits on Δ9 THC, pose structural market-access risk for hemp-derived beverage products. Adverse rulemaking could force reformulation, shrinkable addressable market, or restrict distribution, undermining projected beverage growth and long-term returns.
Tilray News
TLRY FAQ
What was Tilray’s price range in the past 12 months?
Tilray lowest stock price was $3.50 and its highest was $23.20 in the past 12 months.
What is Tilray’s market cap?
Tilray’s market cap is $643.47M.
When is Tilray’s upcoming earnings report date?
Tilray’s upcoming earnings report date is Jul 29, 2026 which is in 55 days.
How were Tilray’s earnings last quarter?
Tilray released its earnings results on Apr 01, 2026. The company reported -$0.224 earnings per share for the quarter, missing the consensus estimate of -$0.136 by -$0.088.
Is Tilray overvalued?
According to Wall Street analysts Tilray’s price is currently Undervalued.
Does Tilray pay dividends?
Tilray does not currently pay dividends.
What is Tilray’s EPS estimate?
Tilray’s EPS estimate is >-0.01.
How many shares outstanding does Tilray have?
Tilray has 119,604,225 shares outstanding.
What happened to Tilray’s price movement after its last earnings report?
Tilray reported an EPS of -$0.224 in its last earnings report, missing expectations of -$0.136. Following the earnings report the stock price went down -5.1%.
Which hedge fund is a major shareholder of Tilray?
Currently, no hedge funds are holding shares in TLRY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Tilray Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$7.97 (16.21% Upside)
$7.97 (16.21% Upside)
Blogger Sentiment
Neutral
TLRY Sentiment 50%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 359.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $232.9K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.6%
Last 30 Days ▼ 5.0%
Last 30 Days ▼ 5.0%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
32.15%
12-Months-Change
Fundamentals
Return on Equity
-92.82%
Trailing 12-Months
Asset Growth
-39.04%
Trailing 12-Months
Company Description
Tilray
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.
TLRY Earnings Call
Q3 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call highlighted clear operational progress: record quarterly revenue, strong international cannabis momentum, meaningful distribution growth, completed cost-savings programs and strategic beverage partnerships/acquisition that materially expand the company’s scale. Several significant challenges remain — beverage revenue and margin pressure, input cost volatility (aluminum, fuel), working capital-related cash use, regulatory uncertainty in the U.S., and integration work for BrewDog — but management presented concrete actions (hedging, Project 420, SKU rationalization, partnerships) and a strengthened liquidity position. On balance, the positive operational and strategic developments outweigh the near-term headwinds.View all TLRY earnings summariesTLRY Stock 12 Month Forecast
Average Price Target
$7.97
▲(16.21% Upside)
Technical Analysis
Ownership Overview
6.79% Insiders
0.42% Mutual Funds
0.97% Other Institutional Investors
88.31% Public Companies and Individual Investors